Financials in USD. Standardized financial statements.
A compact view of how Aspen Pharmacare Holdings Limited turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $43.36B | $44.71B | $40.71B | $38.61B | $37.77B | $38.65B | $38.87B | $42.60B | $41.20B | $35.60B |
| Revenue Growth? | -3.0% | +9.8% | +5.4% | +2.2% | -2.3% | -0.6% | -8.7% | +3.4% | +15.7% | 0.0% |
| Cost of Revenue? | $24.23B | $25.29B | $22.30B | $20.30B | $19.98B | $19.31B | $19.17B | $20.99B | $21.30B | $17.70B |
| Gross Profit? | $19.13B | $19.42B | $18.41B | $18.31B | $17.79B | $19.33B | $19.70B | $21.61B | $19.90B | $17.90B |
| Gross Margin? | +44.1% | +43.4% | +45.2% | +47.4% | +47.1% | +50.0% | +50.7% | +50.7% | +48.3% | +50.3% |
| Operating Expenses? | $17.69B | $12.42B | $11.05B | $9.63B | $10.72B | $10.37B | $10.33B | $11.03B | $11.60B | $8.90B |
| Operating Income? | $1.44B | $7.00B | $7.82B | $8.67B | $7.07B | $7.06B | $4.81B | $9.24B | $8.30B | $9.00B |
| EBITDA? | $2.16B | $9.90B | $10.19B | $9.93B | $8.67B | $7.27B | $5.54B | $9.82B | $9.50B | $9.40B |
| Income Before Tax | -$123.00M | $5.71B | $6.55B | $8.13B | $5.99B | $5.60B | $2.77B | $7.40B | $6.20B | $6.10B |
| Income Tax Expense | $960.00M | $1.31B | $1.33B | $1.65B | $1.19B | $991.00M | $774.00M | $1.39B | $1.10B | $1.80B |
| Net Income? | -$1.08B | $4.40B | $5.23B | $6.49B | $4.81B | $4.66B | $6.46B | $6.01B | $5.10B | $4.30B |
| EPS? | $-2.44 | $9.91 | $11.77 | $14.32 | $10.53 | $10.64 | $14.16 | $13.17 | $11.17 | $9.45 |
| Diluted EPS? | $-2.44 | $9.91 | $11.77 | $14.32 | $10.53 | $10.64 | $14.16 | $13.17 | $11.17 | $9.45 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality